Bristol Myers Squibb says Alzheimer’s is the biggest market for new schizophrenia drug
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Adam ...
Tag: Biogen Inc
Biogen tops profit estimates as cost cuts take hold, Alzheimer’s drug Leqembi launch picks up
A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021.Dado Ruvic ...
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
Signage outside Intel headquarters in Santa Clara, California, Jan. 30, 2023.David Paul Morris | Bloomberg | Getty ImagesCheck out the ...
Eli Lilly expects FDA decision on Alzheimer’s treatment donanemab by the end of the year
Eli Lilly on Monday said it applied for full U.S. Food and Drug Administration approval of its Alzheimer's treatment, donanemab, ...
